PLRX PLIANT THERAPEUTICS, INC.: institutional ownership and insider trading
95 funds reported holding $66.9M of PLIANT THERAPEUTICS, INC. in their latest 13F filings; in Q2 2026 funds net sold $1.83M, with 8 new positions and 13 funds selling out; over the last 12 months insiders bought $0 and sold $164K on the open market.
PLRX revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$22.4M, EPS -0.36
- Quarter ended Mar 31, 2026: revenue n/a, net income −$20.0M, EPS -0.32
- Quarter ended Dec 31, 2025: revenue n/a, net income $275M, EPS -0.37
- Quarter ended Sep 30, 2025: revenue n/a, net income −$26.3M, EPS -0.43
Famous investors holding PLRX
- Two Sigma (Two Sigma Investments): $2.58M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.44M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $2.34M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $638K, 0.0% of the portfolio
Largest institutional holders of PLRX
- TANG CAPITAL MANAGEMENT LLC — $7.00M
- ADAR1 Capital Management, LLC — $6.28M
- Fernwood Investment Management, LLC — $5.60M
- VANGUARD GROUP INC — $3.44M
- VANGUARD CAPITAL MANAGEMENT LLC — $2.78M
- ACADIAN ASSET MANAGEMENT LLC — $2.75M
- Nuveen Asset Management, LLC — $2.73M
- TWO SIGMA INVESTMENTS, LP — $2.58M
- CITADEL ADVISORS LLC — $2.44M
- RENAISSANCE TECHNOLOGIES LLC — $2.34M
Recent PLRX insider trades
- Jan 20, 2026: Kuo Minnie sold 6,917 shares ($8.85K)
- Jan 20, 2026: Coulie Bernard sold 89,375 shares ($114K)
- Jan 20, 2026: Cheung Lily sold 7,534 shares ($9.64K)
- Jan 20, 2026: Cummings Keith Lamont sold 24,002 shares ($30.7K)
5%+ owners
- ADAR1 Capital Management, LLC: 8.9% (Schedule 13G, filed Aug 14, 2026)